Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Quest Pharmatech Inc QPTFF


Primary Symbol: V.QPT

Quest PharmaTech Inc. is a Canadian biopharmaceutical company. The Company is developing products to improve the quality of life. It is developing the proprietary, MAb-AR9.6, targeting MUC16 as a diagnostic agent for cancer. MAb-AR9.6 is licensed from the University of Nebraska Medical Centre and is in late preclinical stage development. The Company has a 42.5% ownership interest in OncoQuest... see more

TSXV:QPT - Post Discussion

Quest Pharmatech Inc > Has the deal gone through?
View:
Post by TrickyGame on Apr 13, 2022 11:15pm

Has the deal gone through?

QPT didn't PR anything about recieving that 1% $1.75 million payment if the deal/merger  was not completed by Feburary 24. Korean regulator had until April 14,2022 to sort this out. It's 12:15 pm April 14 in Korea right now.  The stock is up 30% in a week. Is this finally the end of this long process?
Comment by PosNeg1 on Apr 14, 2022 3:11pm
Nope, insiders exercising options today.
Comment by TrickyGame on Apr 14, 2022 7:15pm
Could they be exercising because they think the deal will go through?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities